Clinical Trial Preference Study

CompletedOBSERVATIONAL
Enrollment

801

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

September 4, 2025

Study Completion Date

September 4, 2025

Conditions
Clinical Trials
Interventions
OTHER

Discrete choice experiment

Participants will state their preferences for 1) return of full versus limited results to participants (trust/personal benefit), 2) balancing a study's participant burden with the study's ability to address multiple research aims (burden/knowledge generation), 3) incentivizing clinical assessments vs. conducting home-based assessments (personal benefit/burden), and 4) results generalizable to specific social groups versus the broader population. Participants will evaluate these attributes within a hypothetical trial to prevent chronic diseases.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Rush University Medical Center

OTHER

NCT06735469 - Clinical Trial Preference Study | Biotech Hunter | Biotech Hunter